| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Performance Measurement of your Businesses Suppliers |
|
Digg It - Performance Measurement of your Businesses Suppliers
The question of how to manage and measure suppliers can be complex. An effective supplier can positively influe According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product nce your bottom line whilst a bad supplier can cause manufacturing delays, impact on the customer and ultimately ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in effect revenues. Supplier measurement doesn’t have to be difficult. By basing measurement around three basic p lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. inciples businesses can begin to analyze their supplier base and begin to identify poorly performing suppliers t here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe at negatively impact their business. These measures are Quality, Cost and Delivery. Quality. Measuring d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro the quality of a supplier refers to the quality of the goods or services supplied. For example how many rejecti ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ons of products appear at goods receipt – are their consistent poor quality products received. Is the technical easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi specification of your orders not met? Quality problems may be categorized depending on the nature of the problem nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically for example is the nature of the problem the goods themselves or accompanying paperwork? Cost Do your and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ uppliers constantly increase their prices – are they inline with the volume of goods purchased. Are there any d ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi scounts received. How do their costs relate to the marketplace. Monitoring cost can be difficult – for example ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a lots or batches purchased may vary, services may be subtly different. Monitoring costs however, is an importan dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod indicator of supplier performance. Delivery Do the suppliers always deliver on time – are you always h cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ving to hasten delivery? One quick way of measuring suppliers is to review their Delivery Schedule Adherence. tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ivide the number of on-time deliveries by the total number of deliveries in a period to obtain the Delivery Sche t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ule Adherence percentage. Analyzing this figure across your supply chain will give you an average figure – how ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust do individual suppliers compare – who are the worst suppliers? How can they be improved? These are three simpl y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ways to measure suppliers. Monitoring these elements over time will enable you to form a basic supplier measur . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ment system that overtime will produce trends. Different organizations may apply different weighting to each me elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip sure – no business is the same but these three areas should form the basis for most supplier measurement systems tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Six Things to Consider Before You Buy or Lease Business Property
|